Q4 2022 Holdings
Filed 2023-02-14 | 17 holdings | $830.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc.(DAWN) | Common Stock | 23954D109 | $162.9M | 7,568,317 | 19.6% |
| Kymera Therapeutics, Inc.(KYMR) | Common Stock | 501575104 | $149.4M | 5,984,736 | 18.0% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $114.4M | 9,869,483 | 13.8% |
| Vigil Neuroscience, Inc.(VIGL) | Common Stock | 92673K108 | $73.0M | 5,836,874 | 8.8% |
| Disc Medicine, Inc.(IRON) | Common Stock | 254604101 | $68.9M | 3,461,784 | 8.3% |
| Aerovate Therapeutics, Inc. | Common Stock | 008064107 | $59.1M | 2,017,521 | 7.1% |
| Replimune Group, Inc.(REPL) | Common Stock | 76029N106 | $57.1M | 2,098,300 | 6.9% |
| Third Harmonic Bio, Inc.(THRD) | Common Stock | 88427A107 | $46.9M | 10,907,859 | 5.6% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $32.6M | 594,251 | 3.9% |
| Generation Bio, Co.(GBIOGBX) | Common Stock | 37148K100 | $32.5M | 8,278,876 | 3.9% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $13.3M | 5,018,178 | 1.6% |
| Xilio Therapeutics, Inc.(XLO) | Common Stock | 98422T100 | $7.4M | 2,759,344 | 0.9% |
| F-star Therapeutics, Inc. | Common Stock | 30315R107 | $3.8M | 599,524 | 0.5% |
| Avrobio Inc | Common Stock | 05455M100 | $3.2M | 4,520,863 | 0.4% |
| Viridian Therapeutics, Inc.(VRDN) | Common Stock | 92790C104 | $2.6M | 90,072 | 0.3% |
| Spero Therapeutics Inc(SPRO) | Common Stock | 84833T103 | $1.8M | 1,031,160 | 0.2% |
| Magenta Therapeutics Inc | Common Stock | 55910K108 | $1.4M | 3,476,536 | 0.2% |